Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on ovarian reserve in reproductive-age women
- Authors: Dolgushina N.V.1, Drapkina Y.S.1, Krechetova L.V.1, Ivanets T.Y.1, Menzhinskaya I.V.1, Gus A.I.1, Bayramova G.R.1, Sukhikh G.T.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
- Issue: No 7 (2021)
- Pages: 81-87
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249362
- DOI: https://doi.org/10.18565/aig.2021.7.81-86
- ID: 249362
Cite item
Open Access
Access granted
Abstract
Relevance. There is limited evidence on the effect of various vaccines on the human reproductive system. Potential adverse effects of vaccines on fertility are associated with autoimmune disorders, which might cause gonadal damage. Currently, several studies are underway investigating the impact of COVID -19 vaccines on human fertility. To our best knowledge, there is only one study published which demonstrated no adverse effects of the COVID -19 vaccine on assisted reproductive technology outcomes. Aim. To investigate the effect of the Gam-COVID-Vac (Sputnik V) vaccine on ovarian reserve and antiphospholipid antibody level in reproductive-age women. Materials and methods. The prospective study included 51 women vaccinated against COVID-19 with GamCOVID-Vac (Sputnik V) vaccine. The inclusion criteria were age from 18 to 45, preserved menstrual function, normal ovarian reserve, no history of COVID-19, negative PCR test result for SARS-CoV-2 and negative SARS-CoV-2 IgG antibody test before vaccination, no pregnancy, and no history of serious illnesses. Clinical evaluation was carried out twice - immediately before immunization and 90 days after the first vaccine component administration. The antral follicle count was measured by pelvic ultrasound. Serum levels of AMH, FSH, TSH, estradiol, antiphospholipid antibodies (aPL) M and G isotypes against cardiolipin (aCL), β2-glycoprotein-1 (aβ2-GP-1), annexin V (aAn V), phosphatidylserine (aPS), and IgG antibodies against SARS-CoV-2 were measured by enzyme immunoassay. Results. There were no significant changes in hormones levels and antral follicle counts before and after vaccination, including in women of advanced reproductive age (≥37 years). After immunization, aPL antibody levels did not differ significantly from the baseline. There was no correlation between aPL antibody level dynamics and level of FSH and AMH, which indirectly demonstrates no possible autoimmune effect of vaccination on women's fertility. Conclusion. This is the first study investigating the effect of the Gam-COVID-Vac vaccine on ovarian reserve parameters and aPL antibody levels. The preliminary results prove that the Gam-COVID-Vac vaccine in women of reproductive age does not adversely impact ovarian reserve
Full Text
About the authors
Nataliya V. Dolgushina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: n_dolgushina@oparina4.ru
Dr. Med. Sci., Deputy Director - Head of the Department of Research Administration
Yulia S. Drapkina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: julia.drapkina@gmail.com
Ph.D., Obstetrition-Gynecologist at the B.V. Leonov Department of Assisted Technologies for the Treatment of Infertility
Lyubov V. Krechetova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: k_l_v_@mail.ru
Dr. Med. Sci., Head of the Laboratory of Clinical Immunology
Tatiana Yu. Ivanets
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: t_ivanets@oparina4.ru
Dr. Med. Sci., Head of the Clinical Diagnostic Laboratory
Irina V. Menzhinskaya
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: i_menzinskaya@oparina4.ru
Dr. Med. Sci., Senior Researcher at the Laboratory of Clinical Immunology
Alexander I. Gus
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: a_gus@oparina4.ru
Dr. Med. Sci., Professor, Head of the Department Ultrasound Diagnostic Imaging
Gyuldana R. Bayramova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: g_bairamova@oparina4.ru
Dr. Med. Sci., Clinical Care Supervisor at the Polyclinic Department
Gennady T. Sukhikh
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: g_sukhikh@oparina4.ru
M.D., Ph.D., Professor, Director
References
- Wacholder S., Chen B.E., Wilcox A., Macones G., Gonzalez P., Befano B. et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ. 2010; 340: c712. https://dx.doi.org/10.1136/bmj.c712.
- Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T. et al. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ. 2015; 351: h4358. https://dx.doi.ois/10.1136/bmj.h4358.
- Wiesen A.R., Littell C.T. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US army women. JAMA. 2002; 287(12): 1556-60. https://dx.doi.org/10.1001/jama.287.12.1556.
- Catherino W.H., Levi A., Kao T.C., Leondires M.P., McKeeby J., Segars J.H. Anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member. Fertil. Steril. 2005; 83(2): 480-3. https://dx.doi.org/10.1016/j.fertnstert.2004.07.965.
- Carp H.J.A., Selmi C., Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J. Autoimmun. 2012; 38(2-3): J266-74. https://dx.doi.org/10.1016/j.jaut.2011.11.016.
- Перминова С.Г. Бесплодие у женщин с аутоиммунной патологией щитовидной железы. Медицинский совет. 2012; 7: 40-4.
- Zivkovic I., Stojanovic M., Petrusic V., Inic-Kanada A., Dimitrijevic L. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice. Am. J. Reprod. Immunol. 2011; 65(5): 492-502. https://dx.doi.org/10.1111/j.1600-0897.2010.00922.x.
- Gharavi A.E., Pierangeli S.S., Espinola R.G., Liu X., Colden-Stanfield M., Harris E.N. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum. 2002; 46(2): 545-52. https://dx.doi.org/10.1002/art.10130.
- Cruz-Tapias P., Blank M., Anaya J.M., Shoenfeld Y. Infections and vaccines in the etiology of antiphospholipid syndrome. Curr. Opin. Rheumatol. 2012; 24(4): 389-93. https://dx.doi.org/10.1097/BOR.0b013e32835448b8.
- Safrai M., Reubinoff B., Ben-Meir A. BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters. medRxiv preprint. May, 2021. https://dx.doi.org/10.1101/2021.04.30.21255690.
- Елагин В.В., Адамян Л.В., Вечорко В.И., Дорошенко Д.А., Дашко А.А., Филиппов О.С., Степанян А.А., Медведева И.В. Вакцинация против COVID-19 и репродуктивное здоровье мужчин (предварительные данные). Проблемы репродукции. 2021; 27(4). DOI 10.17116/ repro2021270410.
- Orvieto R., Noach-Hirsh M., Segev-Zahav A., Haas J., Nahum R., Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients’ performance during IVF-ET cycle? Reprod. Biol. Endocrinol. 2021; 19(1): 69. https://dx.doi.org/10.1186/s12958-021-00757-6.
- Logunov D. Y., Dolzhikova I. V., Shcheblyakov D. V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275): 671-81. https://dx.doi.org/10.1016/S0140-6736(21)00234-8.
- Клинические рекомендации. Женское бесплодие. М.: Российское общество акушеров-гинекологов, Российская ассоциация репродукции человека; 2021. 81с.
- Li M.Y., Li L., Zhang Y., Wang X.S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020; 9(1): 45. https://dx.doi.org/10.1186/s40249-020-00662-x.
- Jing Y., Run-Qian L., Hao-Ran W., Hao-Ran C., Ya-Bin L., Yang G. et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol. Hum. Reprod. 2020; 26(6): 367-73. https://dx.doi.org/10.1093/molehr/gaaa030.
- Smedts A.M., Lele S.M., Modesitt S.C., Curry T.E. Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis. Fertil. Steril. 2006; 86(3): 535-42. https://dx.doi.org/10.1016/j.fertnstert.2006.01.042.
- Li K., Nowak R.A. The role of basigin in reproduction. Reproduction. 2019; REP-19-0268.R1. https://dx.doi.org/10.1530/REP-19-0268.
- Долгушин Г.О., Романов А.Ю. Влияние SARS-COV-2 репродукцию человека. Акушерство и гинекология. 2020; 11: 6-12. [Dolgushin G.O., Romanov A.Yu. Effects of SARS-CoV-2 on human reproduction. Obstetrics and Gynecology. 2020; 11: 6-12. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.11.6-12.
- Ding T., Wang T., Zhang J., Cui P., Chen Z., Zhou S. et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: An Observational Study. Front. Med. 2021; 8: 635255. https://dx.doi.org/10.3389/fmed.2021.635255.
Supplementary files
